Skip to main content
. 2008 Sep 20;3(1):305–309. doi: 10.1007/s12072-008-9102-1

Table 1.

Insulin-like Growth Factor-1 (IGF-1) and Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) levels in patients and controls

N Min Max Mean SD
Control subjects
    Age 28 3 36 17.54 7.66
    Height 28 90 184 150.15 23.93
    IGF-1 (ng/ml) 28 106.0 380.0 233.00 76.98
    IGF-1 (Log normal) 28 −0.718 0.89 −0.04 0.35
    IGFBP-3 (μg/ml) 28 2.90 5.45 4.22 0.77
    IGFBP-3 (Log normal) 28 −0.517 0.70 −0.09 0.25
Patients
    Age 6 40 20.04 8.83
    Height (m) 1.03 1.80 1.51 0.19
    Weight (kg) 14.0 61.5 39.23 12.97
    Hemoglobin (g/dL) 5 15 9.54 2.557
    Total WBC count (/cmm) 1200 16700 5359.62 3618.18
    Platelets (/cmm) 22000 310000 146250.00 75886.78
    Albumin (g/dl) 2.5 34.0 4.21 4.33
    Spleen size at ultrasonography (cm) 9 25 16.76 4.04
    IGF-1 (ng/ml) 52 25.0 392.0 124.71* 65.48
    IGF-1 (Log normal) 52 −2.06 0.03 −0.78* 0.61
    IGFBP-3 (μg/ml) 52 1.0 5.0 2.90* 1.07
    IGFBP-3 (Log normal) 52 −1.84 0.33 −0.61* 0.45

P = 0.001 as compared to control subjects